Biobanking Market worth $12.38 billion by 2031
The report "Biobanking Market by Product (Equipment, Consumables), Software, Services, Workflow (Collection, Storage, Transport), Operation, Sample type (Blood, Stem Cells, Nucleic Acid), Application, Ownership, Region, End User, Competition - Global Forecast to 2031", The global biobanking market is projected to reach USD 12.38 billion by 2031, up from USD 8.09 billion in 2026, at a CAGR of 8.9% over the forecast period. The global biobanking market is growing, driven by increasing access to high-quality, integrated omics data for research.
Browse 650 market data Tables and 51 Figures spread through 600 Pages and in-depth TOC on "Biobanking Market by Product (Equipment, Consumables), Software, Services, Workflow (Collection, Storage, Transport), Operation, Sample type (Blood, Stem Cells, Nucleic Acid), Application, Ownership, Region, End User, Competition - Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/biobanking-devices-market-594.html
The sample collection & storage segment accounted for the largest share of the global biobanking market, by workflow, in 2025.
Based on workflow, the biobanking market is segmented into sample collection & storage, sample processing, sample analysis, and transport & logistics. In 2025, the sample collection & storage segment accounted for the largest share of the market, driven by the critical importance of proper biospecimen collection, preservation, and long-term storage to maintain sample quality and integrity. Growing demand for high-quality biological samples for genomics, drug discovery, precision medicine, clinical research, and cell and gene therapy is increasing the need for reliable collection and storage infrastructure. Furthermore, the adoption of ultra-low-temperature (ULT) freezers, cryogenic storage systems, automated biobanking platforms, and temperature-monitoring technologies is enhancing sample preservation and inventory management. The increasing volume and diversity of biospecimens stored by pharmaceutical and biotechnology companies, academic institutions, hospitals, and commercial biobanks further support the segment's leading position.
By end user, the pharmaceutical & biotechnology companies & CROs segment is estimated to register the highest growth in the biobanking services market during the forecast period.
By end user, the biobanking services market is segmented into pharmaceutical & biotechnology companies, CROs, and academic & research institutes. The pharmaceutical & biotechnology companies and CROs segment is expected to register the highest growth rate during the forecast period, driven by increasing investments in drug discovery, biologics, biosimilars, and advanced therapies such as cell and gene therapies. The growing complexity of therapeutic development is increasing the need for high-quality biological samples, cell lines, and standardized sample management solutions. In addition, the expansion of clinical research and clinical trial activities is driving demand for biospecimen collection, processing, storage, and management services among pharmaceutical, biotechnology, and CRO organizations.
North America accounted for the largest regional share in the global biobanking market in 2025.
The biobanking market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. In 2025, North America held the largest share of the global biobanking market, driven by its well-established pharmaceutical and biotechnology ecosystem, strong investments in biomedical and precision medicine research, and early adoption of advanced biobanking technologies. The region benefits from substantial government and institutional funding for life sciences research, well-developed biobank networks, and leading biobanking technology and service providers. In addition, rising demand for high-quality biological samples to support oncology research, biomarker discovery, drug development, clinical research, and personalized medicine continues to strengthen North America's dominant market position. The growing adoption of automated sample storage, digital sample management, and advanced preservation technologies further supports regional market growth.
Key players include Thermo Fisher Scientific (US), PHC Holdings Corporation (Japan), Becton, Dickinson and Company (BD) (US), Qiagen (Germany), and Merck KGaA (Germany).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Biobanking Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
